Michael Schmidt

Stock Analyst at Guggenheim

(0.94)
# 2001
Out of 5,329 analysts
138
Total ratings
46.77%
Success rate
-6.22%
Average return
50 Stocks
Name Action PT Current % Upside Ratings Updated
SWTX SpringWorks Therapeu...
Downgrades: Neutral
77 47
46.24 1.64% 2 Apr 29, 2025
CMPX Compass Therapeutics
Reiterates: Buy
n/a
n/a n/a 3 Apr 22, 2025
ONC BeiGene
Reiterates: Buy
n/a
n/a n/a 2 Apr 16, 2025
NBTX Nanobiotix
Maintains: Buy
12 8
3.31 141.69% 2 Apr 4, 2025
ADCT ADC Therapeutics
Maintains: Buy
10 7
1.44 386.11% 4 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
109 109
45.4 140.09% 5 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 2
0.28 525% 3 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
7.46 87.67% 3 Mar 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 25
8.88 181.53% 2 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
92 92
62.09 48.17% 5 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
57 32
7.24 341.99% 4 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 1 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
21.13 112.97% 1 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 5 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
42 42
38.9 7.97% 8 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 1 Jan 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
3.44 481.4% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
82 87
40.69 113.81% 2 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 8
1.46 447.95% 3 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7
0.4 1650% 2 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
350 345
n/a n/a 4 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 31
n/a n/a 1 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 34
10.89 212.21% 4 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
40 42
13.78 204.79% 2 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
104 60
n/a n/a 10 Jul 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20
0.63 3074.6% 3 Jun 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
170
n/a n/a 3 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
1.49 1577.85% 1 Aug 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
4.9 512.24% 1 Jul 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26
4.58 467.69% 1 May 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 39
n/a n/a 1 Apr 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 27, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 48
n/a n/a 2 Dec 11, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Mar 5, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
80
31.03 157.82% 4 Feb 15, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 4 Jan 17, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
30
n/a n/a 2 Sep 25, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Outperform
24
n/a n/a 3 Sep 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
56 87
n/a n/a 4 Jan 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
4 6
3.6 52.78% 2 Nov 7, 2017